Is tetrahydrobiopterin a therapeutic option in diabetic hypertensive patients?

References

• GhanemFAMovahedAInflammation in high blood pressure: A clinical perspectiveJ Am Soc Hypertens2007111311920409841
   PubMed Web of Science ®Google Scholar
• Rubio-GuerraAFVargas-RoblesHVargas-AyalaGRodríguez-LopezLEscalante-AcostaBAThe effect of trandolapril and its fixed-dose combination with verapamil on circulating adhesion molecules levels in hypertensive patients with type 2 diabetesClin Exp Hypertens20083068268818855271
   PubMed Web of Science ®Google Scholar
• RubioAFVargasHMacedaALozanoJJEscalanteBACorrelation between the levels of circulating adhesion molecules and atherosclerosis in type-2 diabetic normotensive patientsCell Adh Migr2009336937219717975
   PubMed Web of Science ®Google Scholar
• MadamanchiNRVendrovARungeMSOxidative stress and vascular diseaseArterioscler Thromb Vasc Biol200525293815539615
   PubMed Web of Science ®Google Scholar
• GriendlingKKSorescuDUshio-FukaiMNAD(P)H oxidase: Role in cardiovascular biology and diseaseCirc Res20008649450110720409
   PubMed Web of Science ®Google Scholar
• KimJMontagnamiMKonKQuonMJReciprocal relations between insulin resistance and endothelial dysfunctionCirculation20061131888190416618833
   PubMed Web of Science ®Google Scholar
• KwonNSNathanCFStuerhrDJReduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophagesJ Biol Chem198926420496205012584226
   PubMed Web of Science ®Google Scholar
• AlpNJChannonKMRegulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular diseaseArterioscler Thromb Vasc Biol20052441342014656731
   PubMed Web of Science ®Google Scholar
• GrossSJonesSHattoriCLRamanCSTetrahydrobiopterin: An essential cofactor of nitric oxide synthase with an elusive roleIgnarroLJNitric Oxide Biology and PathobiologyNew York, NYAcademic Press2000
   Google Scholar
• HurshmanARKrebsCEdmondsonDHuynhBHMarlettaMAFormation of a pterin radical in the reaction of the heme domain of inducible nitric oxide synthase with oxygenBiochemistry199938156891569610625434
   PubMed Web of Science ®Google Scholar
• BauersachsJWidderJDTetrahydrobiopterin, endothelial nitric oxide synthase, and mitochondrial function in the heartHypertension20095390790819398653
   PubMed Web of Science ®Google Scholar
• SchmidtTSAlpNJMechanisms for the role of tetrahydrobiopterin in endothelial function and vascular diseaseClin Sci2007113476317555404
   PubMed Web of Science ®Google Scholar
• GesierichANiroomandFTiefenbavherCPRole of human GTP cyclohydrolase I and its regulatory protein in tetrahydrobiopterin metabolismBasic Res Cardiol200298697512607127
   PubMed Web of Science ®Google Scholar
• WuGKellyKAHatakeyamaKMeiningerCJRegulation of endothelial tetrahydrobiopterin synthesis by l-arginineBlauNThonyBPterins, Folates and Neurotransmitters in Molecular MedicineHeilbronnSPS Verlagsgesellschaft mbH2004
   Google Scholar
• IshiiMShimizuSNagaiTShiotaKKiruchiYYamamotoTStimulation of tetrahydrobiopterin synthesis by insulin: Possible involvement of phosphatidylinositol 3-kinaseInt J Biochem Cell Biol200133657311167133
   PubMed Web of Science ®Google Scholar
• ShiotaKIshiiMYamamotoTShimizuSKiuchiYStimulation of tetrahydrobiopterin synthesis by 17β-estradiol in brain microvascular endothelial cellsPteridines200011129132
   Web of Science ®Google Scholar
• Rosenkrantz-WeissPSessaWCMilsteinSKaufmanSWatsonCAPoberJSRegulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cellsJ Clin Invest199493223622437514193
   PubMed Web of Science ®Google Scholar
• IshiiMShimizuSShiotaKYamamotoSKiuchiYYamamotoTStimulation of tetrahydrobiopterin synthesis by cyclosporin A during lipopolysaccharide treatment in vascular endothelial cellsPteridines2002138993
   Web of Science ®Google Scholar
• JohnsDGDorranceAMTramontiniNLWebbRCGlucocorticoids inhibit tetrahydrobiopterin-dependent endothelial functionExp Biol Med20012262731
   PubMed Web of Science ®Google Scholar
• SchoedonGScheemannMBlauNEdgellCJSChafnerAModulation of human endothelial cell tetrahydrobiopterin synthesis by activating and deactivating cytokines: New perspectives on endothelium-derived relaxing factorBiochem Biophys Res Comm1993196134313488250889
   PubMed Web of Science ®Google Scholar
• KohliRMeiningerCJHaynesTEYanWSelfJTWuGDietary L-arginine supplementation enhances endothelial nitric oxide synthesis in streptozotocin-induced diabetic ratsJ Nutr200413460060914988454
   PubMed Web of Science ®Google Scholar
• LaursenJBSomersMKurzSEndothelial regulation of vasomotion in ApoE-deficient mice. Implications for interactions between peroxynitrite and tetrahydrobiopterinCirculation20011031282128811238274
   PubMed Web of Science ®Google Scholar
• BakerHMilstienSKatusikZSEffect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cellsJ Cardiovasc Pharmacol20013733333811243424
   PubMed Web of Science ®Google Scholar
• KnowlesRGMoncadaSMammalian nitric oxide synthaseBiochem J19942982492547510950
   PubMed Web of Science ®Google Scholar
• CosentinoFLuscherTFTetrahydrobiopterin and endothelial nitric synthase activityCardiovasc Res19994327427810536654
   PubMed Web of Science ®Google Scholar
• WhitsettJMartasekPZhaoHEndothelial cell superoxide anion radical generation is not dependent on endothelial nitric oxide synthaseserine 1179 phosphorylation and endothelial nitric oxide dimer/monomer distributionFree Rad Biol Med2006402056205816716906
   PubMed Web of Science ®Google Scholar
• Vazquez-VivarJTetrahydrobiopterin, superoxide and vascular dysfunctionFree Rad Biol Med2009471108111919628033
   PubMed Web of Science ®Google Scholar
• CrabtreeMJSmithCILamGGoligorskyMSGrossSSRatio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs superoxide production by eNOSAm J Physiol Heart Circ Physiol2008294H1530H154018192221
   PubMed Web of Science ®Google Scholar
• ZouMHShiCCohenRAOxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitriteJ Clin Invest200210981782611901190
   PubMed Web of Science ®Google Scholar
• YangYHuangAKaleyGSunDeNOS uncoupling and endothelial dysfunction in aged vesselsAm J Physiol Heart Circ Physiol2009297H1829H183619767531
   PubMed Web of Science ®Google Scholar
• StuehrDPouSRosenGMOxygen reduction by nitric-oxide synthasesJ Biol Chem2001276145331453611279231
   PubMed Web of Science ®Google Scholar
• HeitzerTKrohnKAlbersSMeinertzTTetrahydrobiopterin improves endothelial vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitusDiabetologia2000431435143811126415
   PubMed Web of Science ®Google Scholar
• LandmesserUDikalovSPriceSROxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertensionJ Clin Invest20031111201120912697739
   PubMed Web of Science ®Google Scholar
• KatusicZSd’UscioLNathKAVascular protection by tetrahydrobiopterin: Progress and therapeutic prospectsTrends Pharmacol Sci200930485419042039
   PubMed Web of Science ®Google Scholar
• ArtuncFEssigMArtuncNEffects of tetrahydrobiopterin on nitric oxide bioavailability and renal hemodynamics in healthy volunteersJ Nephrol20082185086019034869
   PubMed Web of Science ®Google Scholar
• AlpNJMcAteerMAKhooJChoudhuryRPChannonKMIncreased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout miceArterioscler Thromb Vasc Biol20042444545014707037
   PubMed Web of Science ®Google Scholar
• IhlemannNRask-MadsenCHTetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjectsAm J Physiol2003285H875H882
   Google Scholar
• PorkertMSherSReddyUTetrahydrobiopterin: A novel anti-hypertensive therapyJ Hum Hypertens20082240140718322548
   PubMed Web of Science ®Google Scholar
• SettergrenMBöhmFMalmströmREChannonKMPernowJL-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery diseaseAtherosclerosis2009204737818849028
   PubMed Web of Science ®Google Scholar
• WilsonAMHaradaRNairNBalasubramanianNCookeJPL-arginine supplementation in peripheral arterial disease: No benefit and possible harmCirculation200711618819517592080
   PubMed Web of Science ®Google Scholar
• SommerFKlotzTSteineritzDBlochWEvaluation of tetrahydrobiopterin as a potential therapeutic agent to treat erectile dysfunctionAsian J Androl2006815916716491266
   PubMed Web of Science ®Google Scholar
• HattoriYHattoriSWangXSatohHNakanishiNKasaiKOral administration of tetrahydrobiopterin slows the progression of atherosclerosis in apolipoprotein E-knockout miceArterioscler Thromb Vasc Biol20072786587017272747
   PubMed Web of Science ®Google Scholar
• RubioAFVargasGLozanoJJNarvaezJLRodriguezLComparison between isosorbide dinitrate aerosol and nifedipine in the management of hypertensive emergenciesJ Hum Hypertens19991347347610449212
   PubMed Web of Science ®Google Scholar
• LiHFörstermannUPrevention of atherosclerosis by interference with the vascular nitric oxide systemCurr Pharm Des2009153133314519754387
   PubMed Web of Science ®Google Scholar
• TenenbaumAFismanEZMotroML-arginine: Rediscovery in progressCardiology1998901531599892762
   PubMed Web of Science ®Google Scholar
• BogerRHThe pharmacodynamics of L-arginineJ Nutr2007137S1650S1655
   PubMed Web of Science ®Google Scholar
• StroesESGvan FaassenEEYoMFolic acid reverts dysfunction of endothelial nitric oxide synthaseCirc Res2000861129113410850963
   PubMed Web of Science ®Google Scholar
• The Heart Outcomes Prevention Evaluation (HOPE) 2 InvestigatorsHomocysteine lowering with folic acid and B vitamins in vascular diseaseN Engl J Med20063541567157716531613
   PubMed Web of Science ®Google Scholar
• AlpNJMussaSKhooJTetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP–cyclohydrolase I overexpressionJ Clin Invest200311272573512952921
   PubMed Web of Science ®Google Scholar
• LaufsULa FataVPlutzkyJLiaoJKUpregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitorsCirculation199897112911359537338
   PubMed Web of Science ®Google Scholar
• HattoriYNakanishiNAkimotoKYoshidaMKasaiKHMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetra-hydrobiopterin in vascular endothelial cellsArterioscler Thromb Vasc Biol20032317618212588756
   PubMed Web of Science ®Google Scholar
• NissenSETuzcuEMSchoenhagenPEffect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trialJAMA20042911071108014996776
   PubMed Web of Science ®Google Scholar
• NickeningGHarrisonDGThe AT1-type angiotensin receptor in oxidative stress and atherogenesis. Part 1Circulation200210539339611804998
   PubMed Web of Science ®Google Scholar
• DavidBMatcharDBMcCroryDCSystematic review: Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertensionAnn Intern Med2008148162917984484
   PubMed Web of Science ®Google Scholar
• ImanishiTIkejimaHTsujiokaHAddition of eplerenone to an angiotensin-converting enzyme inhibitor effectively improves nitric oxide bioavailabilityHypertension20085173474118227404
   PubMed Web of Science ®Google Scholar
• ImanishiTTsujiokaHIkejimaHRenin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changesHypertension20085256357218645051
   PubMed Web of Science ®Google Scholar